Global Sterility Indicators Market Size, Share & Trends 2014-2018 & 2025 by Type (Chemical, Biological), & Technique (Heat, Low Temperature, Filtration, Radiation, Liquid) – ResearchAndMarkets.com
The global sterility indicators market size is expected to reach
It is anticipated to expand at a CAGR of 10.9% over the forecast period. Strict regulations regarding healthcare products and high emphasis on sterility parameters and measures for the prevention of Hospital Acquired Infections (HAIs) are projected to drive the market growth.
Increasing number of geriatric population prone to chronic conditions is primarily driving the demand for drugs and medical devices globally. Governments in developing economies like
Currently,
Standardized manufacturing protocols, introduction of novel products, and adoption of new technologies has led to harmonization of quality and sterility testing standards in the healthcare industry. This has created a need for not only aseptic manufacturing techniques but also for efficient and reliable sterilization monitoring processes.
Furthermore, organizations such as the
Further key findings from the study suggest:
- Biological indicator segment captured the largest market share in 2017. Extensive usage as compared to chemical indicators owing to their reliability is anticipated to propel the segment growth
-
North America is expected to maintain its dominance with the largest market share over the forecast period owing to the presence of a large number of major companies and a high adoption of advanced technologies -
Asia Pacific is expected to exhibit a lucrative CAGR during the forecast period. Presence of a large untapped market and availability of supportive government regulations are expected to attract global players - Some of the major players in the sterility indicators market include Getinge AB; Cantel Medical Corporation; 3M Company; Cardinal Health Inc.;
Matachana Group ; Mesa Laboratories; andAnderson Products Inc.
Key Topics Covered:
Chapter 1 Methodology And Scope
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
Chapter 4 Market Definitions
Chapter 5 Industry Outlook
5.1 Market Variable Analysis
5.1.1 Supportive Government Investment In The Healthcare Industry
5.1.2 Increasing R & D Activities
5.1.3 Increasing Number Of Drug Launches
5.1.4 Increasing Focus On Quality And Sterility
5.1.5 Rising Burden Of Hospital Acquired Infections
5.1.6 Increasing Application Of Sterilization In Pharmaceutical And Biotechnology Industry
5.2 Market Restraint Analysis
5.2.1 Influx Of Low Quality Products From Local Manufacturers
Chapter 6 Business Environment Analysis
6.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
6.2 Porter's Five Forces Analysis
Chapter 7 Type Business Analysis
7.1 Sterility Indicators Market: Type Movement Analysis
7.1.1 Chemical Indicators
7.1.1.1 Chemical Indicators Estimates And Forecast, 2014 - 2025
7.1.1.2 Class 1 Indicators
7.1.1.3 Class 2 Indicators
7.1.1.4 Class 3 Indicators
7.1.1.5 Class 4 Indicators
7.1.1.6 Class 5 Indicators
7.1.1.6.1 Class 5 Indicators Market Estimates And Forecast, 2014 - 2025
7.1.1.6.2 Tapes
7.1.1.6.3 Strips
7.1.1.6.4 Others
7.1.2 Biological Indicators
7.1.2.1 Biological Indicators Market Estimates And Forecast, 2014 - 2025
7.1.2.2 Spore Ampoules
7.1.2.3 Spore Suspensions
7.1.2.4 Self - Contained Vials
7.1.2.5 Spore Strips
Chapter 8 Technique Business Analysis
8.1 Sterility Indicators Market: Technique Movement Analysis
8.1.1 Heat Sterilisation
8.1.2 Low Temperature Sterilisation
8.1.3 Filtration Sterilisation
8.1.4 Radiation Sterilization
8.1.5 Liquid Sterilisation
Chapter 9 End User Business Analysis
9.1 Sterility Indicators Market: End - User Movement Analysis
9.1.1 Hospitals
9.1.1.1 Hospitals Market Estimates And Forecast, 2014 - 2025
9.1.1.2 Pharmaceutical Companies
9.1.1.3 Medical Device Companies
9.1.1.4
9.1.1.5 Others
Chapter 10 Regional Business Analysis
10.1 Sterility Indicators Market: Regional Movement Analysis
10.1.1
10.1.1.1 North America Market Estimates And Forecast, 2014 - 2025
10.1.1.2
10.1.1.3
10.1.2
10.1.2.1 Europe Market Estimates And Forecast, 2014 - 2025
10.1.2.2
10.1.2.3
10.1.2.4
10.1.2.5
10.1.2.6
10.1.2.7
10.1.2.8
10.1.3
10.1.3.1 Asia - Pacific Market Estimates And Forecast, 2014 - 2025
10.1.3.2
10.1.3.3
10.1.3.4
10.1.4
10.1.4.1 Latin America Market Estimates And Forecast, 2014 - 2025
10.1.4.2
10.1.4.3
10.1.4.4
10.1.5 Middle East And Africa
10.1.5.1 Middle - East And Africa Market Estimates And Forecast, 2014 - 2025
10.1.5.2
10.1.5.3
10.1.5.4
Chapter 11 Company Profiles
- Getinge Ab
- Cantel Medical Corporation
- 3m Company
- Cardinal Health
-
Matachana Group - Mesa Laboratories
- Anderson Products , Inc.
For more information about this report visit https://www.researchandmarkets.com/r/dx69f2
View source version on businesswire.com: https://www.businesswire.com/news/home/20190425005424/en/
ResearchAndMarkets.com
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics
Source:
Sheltering in place during a wildfire a dicey strategy
Governor Cuomo Announces $4.8 Million to Complete Cleanup of Four Contaminated Sites
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News